Prior authorization refers to a process in which your healthcare provider requests approval from your insurer to prescribe you a medication
Procedures Participants were administered subcutaneous semaglutide 2.4 mg or a placebo once a week for 104 weeks, alongside standard behavioral intervention, followed by a 7-week period without treatment
By June, employers, health systems, and PBMs have something far more valuable than forecasts: six months of real-world claims experience
The large majority, roughly 70% to 80%, fell within a meaningful range that included the advertised average
Conclusion Semaglutide represents a promising option for individuals looking to manage their weight effectively
Healthcare providers typically monitor hemoglobin A1c, fasting blood glucose, lipid panels, kidney function tests (creatinine, eGFR, UACR), and liver function tests to assess treatment efficacy and safety